Table 4 Comparison between group I (control group) and group II (case group) regarding levels of hemoglobin, AST, ALT, albumin, total bilirubin, INR, platelets, and creatinine 4 weeks after treatment

Hemoglobin (gm/dl)

Mean ± SD

12.63 ± 1.59

10.27 ± 1.97

6.581

0.001

Range

8.8–16

7.1–15.1

AST (U/L)

Normal

49 (98.0%)

47 (94%)

1.042

0.307

High

1 (2%)

3 (6%)

ALT (U/L)

Normal

45 (90%)

47 (94%)

0.543

0.461

High

5(10%)

3(6%)

Albumin (gm/dl)

Mean ± SD

4.26 ± 0.40

4.03 ± 0.57

2.261

0.026

Range

3.2–5.4

2.7–5.3

Bilirubin (mg/dl)

Mean ± SD

0.99 ± 0.43

0.73 ± 0.33

3.324

0.001

Range

0.2–2

0.2–2

INR

Mean ± SD

1.08 ± 0.13

1.05 ± 0.08

1.197

0.234

Range

1–1.65

0.9–1.21

Platelets (10³/mm³)

Mean ± SD

250.27 ± 92.85

213.56 ± 69.12

2.234

0.028

Range

132–663

92–430

Creatinine (mg/dl)

Median (IQR)

0.88 (0.7–0.95)

7.38 (5.6–9)

− 8.634

0.001

Range

0.3–1.2

3–16.8